• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高磷血症会增加炎症反应,从而加重贫血和骨骼肌消耗,而与 FGF23-FGFR4 信号无关。

Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling.

机构信息

Division of Nephrology and Hypertension, Department of Medicine, The University of Alabama at Birmingham, Birmingham, United States.

Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, United States.

出版信息

Elife. 2022 Mar 18;11:e74782. doi: 10.7554/eLife.74782.

DOI:10.7554/eLife.74782
PMID:35302487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8963881/
Abstract

Elevations in plasma phosphate concentrations (hyperphosphatemia) occur in chronic kidney disease (CKD), in certain genetic disorders, and following the intake of a phosphate-rich diet. Whether hyperphosphatemia and/or associated changes in metabolic regulators, including elevations of fibroblast growth factor 23 (FGF23) directly contribute to specific complications of CKD is uncertain. Here, we report that similar to patients with CKD, mice with adenine-induced CKD develop inflammation, anemia, and skeletal muscle wasting. These complications are also observed in mice fed high phosphate diet even without CKD. Ablation of pathologic FGF23-FGFR4 signaling did not protect mice on an increased phosphate diet or mice with adenine-induced CKD from these sequelae. However, low phosphate diet ameliorated anemia and skeletal muscle wasting in a genetic mouse model of CKD. Our mechanistic in vitro studies indicate that phosphate elevations induce inflammatory signaling and increase hepcidin expression in hepatocytes, a potential causative link between hyperphosphatemia, anemia, and skeletal muscle dysfunction. Our study suggests that high phosphate intake, as caused by the consumption of processed food, may have harmful effects irrespective of pre-existing kidney injury, supporting not only the clinical utility of treating hyperphosphatemia in CKD patients but also arguing for limiting phosphate intake in healthy individuals.

摘要

血浆磷酸盐浓度升高(高磷酸盐血症)发生在慢性肾脏病(CKD)、某些遗传疾病以及摄入富含磷酸盐的饮食后。高磷酸盐血症和/或代谢调节剂的相关变化,包括成纤维细胞生长因子 23(FGF23)的升高,是否直接导致 CKD 的特定并发症尚不确定。在这里,我们报告说,类似于 CKD 患者,腺嘌呤诱导的 CKD 小鼠会发生炎症、贫血和骨骼肌消耗。即使没有 CKD,高磷酸盐饮食也会导致这些并发症在小鼠中发生。病理性 FGF23-FGFR4 信号的缺失并不能保护高磷酸盐饮食的小鼠或腺嘌呤诱导的 CKD 小鼠免受这些后果的影响。然而,低磷酸盐饮食可改善 CKD 遗传小鼠模型中的贫血和骨骼肌消耗。我们的体外机制研究表明,磷酸盐升高可诱导肝细胞中的炎症信号和铁调素表达增加,这是高磷酸盐血症、贫血和骨骼肌功能障碍之间的潜在因果关系。我们的研究表明,高磷酸盐摄入(如摄入加工食品引起)可能有害,而与预先存在的肾损伤无关,这不仅支持了治疗 CKD 患者高磷酸盐血症的临床实用性,也支持了限制健康人群磷酸盐摄入的观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/d0bc040eb45f/elife-74782-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/6adb4c07c082/elife-74782-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/052015e8829a/elife-74782-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/ac5d73116cdc/elife-74782-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/60f077a76dde/elife-74782-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/b0bafbca67d1/elife-74782-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/71eeb6660bfa/elife-74782-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/de1f2771185a/elife-74782-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/ce9fa83ea8ab/elife-74782-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/59e13f891a38/elife-74782-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/38ae54031dd1/elife-74782-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/53e77bcb8535/elife-74782-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/9b0e0b16b189/elife-74782-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/553835404f63/elife-74782-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/7f6d60255f14/elife-74782-fig7-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/d0bc040eb45f/elife-74782-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/6adb4c07c082/elife-74782-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/052015e8829a/elife-74782-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/ac5d73116cdc/elife-74782-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/60f077a76dde/elife-74782-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/b0bafbca67d1/elife-74782-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/71eeb6660bfa/elife-74782-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/de1f2771185a/elife-74782-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/ce9fa83ea8ab/elife-74782-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/59e13f891a38/elife-74782-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/38ae54031dd1/elife-74782-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/53e77bcb8535/elife-74782-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/9b0e0b16b189/elife-74782-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/553835404f63/elife-74782-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/7f6d60255f14/elife-74782-fig7-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beff/8963881/d0bc040eb45f/elife-74782-fig8.jpg

相似文献

1
Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling.高磷血症会增加炎症反应,从而加重贫血和骨骼肌消耗,而与 FGF23-FGFR4 信号无关。
Elife. 2022 Mar 18;11:e74782. doi: 10.7554/eLife.74782.
2
Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice.膳食铁摄入量和慢性肾脏病对野生型和铁调素基因敲除小鼠成纤维细胞生长因子23代谢的影响。
Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1369-F1377. doi: 10.1152/ajprenal.00281.2016. Epub 2016 Oct 12.
3
Hyperphosphatemia Contributes to Skeletal Muscle Atrophy in Mice.高磷血症导致小鼠骨骼肌萎缩。
Int J Mol Sci. 2024 Aug 28;25(17):9308. doi: 10.3390/ijms25179308.
4
Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.成纤维细胞生长因子23直接作用于肝细胞以促进慢性肾脏病中的炎症反应。
Kidney Int. 2016 Nov;90(5):985-996. doi: 10.1016/j.kint.2016.05.019. Epub 2016 Jul 22.
5
The HIF-PHI BAY 85-3934 (Molidustat) Improves Anemia and Is Associated With Reduced Levels of Circulating FGF23 in a CKD Mouse Model.HIF-PHI BAY 85-3934(莫立司他)可改善贫血,并与 CKD 小鼠模型中循环 FGF23 水平降低相关。
J Bone Miner Res. 2021 Jun;36(6):1117-1130. doi: 10.1002/jbmr.4272. Epub 2021 Mar 10.
6
Hypericin Alleviates Chronic Kidney Disease-induced Left Ventricular Hypertrophy by Regulation of FGF23-FGFR4 Signaling Pathway.金丝桃素通过调节 FGF23-FGFR4 信号通路缓解慢性肾脏病诱导的左心室肥厚。
J Cardiovasc Pharmacol. 2024 Jun 1;83(6):588-601. doi: 10.1097/FJC.0000000000001559.
7
Fibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner.成纤维细胞生长因子 23(FGF23)通过成纤维细胞生长因子受体 4 依赖性方式诱导小鼠室性心律失常和延长 QT 间期。
Am J Physiol Heart Circ Physiol. 2021 Jun 1;320(6):H2283-H2294. doi: 10.1152/ajpheart.00798.2020. Epub 2021 Apr 30.
8
The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia.成纤维细胞生长因子 23 在炎症和贫血中的作用。
Int J Mol Sci. 2019 Aug 27;20(17):4195. doi: 10.3390/ijms20174195.
9
Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.柠檬酸铁降低了慢性肾病小鼠模型中成纤维细胞生长因子 23 的水平,并改善了其肾功能和心功能。
Kidney Int. 2019 Dec;96(6):1346-1358. doi: 10.1016/j.kint.2019.07.026. Epub 2019 Aug 30.
10
Chronic Kidney Disease-associated Lung Injury Is Mediated by Phosphate-induced MAPK/AKT Signaling.慢性肾脏病相关肺损伤是由磷酸盐诱导的 MAPK/AKT 信号通路介导的。
Am J Respir Cell Mol Biol. 2024 Dec;71(6):659-676. doi: 10.1165/rcmb.2024-0008OC.

引用本文的文献

1
Multiscale Analysis Reveals Altered Characteristics in Femur and Mandible of Mice on a High Phosphate Diet.多尺度分析揭示高磷饮食小鼠股骨和下颌骨的特征改变。
Calcif Tissue Int. 2025 Aug 27;116(1):114. doi: 10.1007/s00223-025-01425-2.
2
Soft tissue calcifications in chronic kidney disease-beyond the vasculature.慢性肾脏病中的软组织钙化——血管系统之外
Pflugers Arch. 2025 Jun 5. doi: 10.1007/s00424-025-03098-0.
3
The Pathologic Actions of Phosphate in CKD.慢性肾脏病中磷酸盐的病理作用

本文引用的文献

1
Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression.肾管状液中的磷酸钙微晶加速慢性肾病进展。
J Clin Invest. 2021 Aug 16;131(16). doi: 10.1172/JCI145693.
2
A chronic high phosphate intake in mice is detrimental for bone health without major renal alterations.小鼠长期高磷摄入对骨骼健康有害,且不会引起严重的肾脏改变。
Nephrol Dial Transplant. 2021 Jan 30. doi: 10.1093/ndt/gfab015.
3
High phosphate induces skeletal muscle atrophy and suppresses myogenic differentiation by increasing oxidative stress and activating Nrf2 signaling.
Kidney360. 2025 Apr 17;6(6):1040-1049. doi: 10.34067/KID.0000000820.
4
Uric Acid Correlates with Serum Levels of Mineral Bone Metabolism and Inflammation Biomarkers in Patients with Stage 3a-5 Chronic Kidney Disease.尿酸与3a - 5期慢性肾脏病患者的血清矿物质骨代谢及炎症生物标志物水平相关。
Medicina (Kaunas). 2024 Dec 19;60(12):2081. doi: 10.3390/medicina60122081.
5
Hyperphosphatemia Contributes to Skeletal Muscle Atrophy in Mice.高磷血症导致小鼠骨骼肌萎缩。
Int J Mol Sci. 2024 Aug 28;25(17):9308. doi: 10.3390/ijms25179308.
6
Chronic Kidney Disease-associated Lung Injury Is Mediated by Phosphate-induced MAPK/AKT Signaling.慢性肾脏病相关肺损伤是由磷酸盐诱导的 MAPK/AKT 信号通路介导的。
Am J Respir Cell Mol Biol. 2024 Dec;71(6):659-676. doi: 10.1165/rcmb.2024-0008OC.
7
The role of osteopontin and osteocyte-derived factors in secondary hyperparathyroidism-induced myopathy.骨桥蛋白和骨细胞衍生因子在继发性甲状旁腺功能亢进性肌病中的作用。
JBMR Plus. 2024 Jun 28;8(8):ziae084. doi: 10.1093/jbmrpl/ziae084. eCollection 2024 Aug.
8
Skeletal Muscle Injury in Chronic Kidney Disease-From Histologic Changes to Molecular Mechanisms and to Novel Therapies.慢性肾脏病中的骨骼肌损伤——从组织学变化到分子机制再到新疗法。
Int J Mol Sci. 2024 May 8;25(10):5117. doi: 10.3390/ijms25105117.
9
Potential application of anti-osteoporotic therapy to relieve sarcopenia in the elderly.抗骨质疏松治疗在缓解老年人肌肉减少症方面的潜在应用。
Ann Med Surg (Lond). 2023 Oct 4;85(12):6008-6012. doi: 10.1097/MS9.0000000000001352. eCollection 2023 Dec.
10
Oh, My Gut! New insights on the role of the gastrointestinal tract and the gut microbiome in chronic kidney disease-mineral and bone disorder.哦,我的肠道!关于胃肠道和肠道微生物群在慢性肾脏病 - 矿物质和骨异常中作用的新见解
Curr Opin Nephrol Hypertens. 2024 Mar 1;33(2):226-230. doi: 10.1097/MNH.0000000000000961. Epub 2023 Dec 13.
高磷通过增加氧化应激和激活 Nrf2 信号通路诱导骨骼肌萎缩和抑制成肌分化。
Aging (Albany NY). 2020 Nov 2;12(21):21446-21468. doi: 10.18632/aging.103896.
4
Intracellular Phosphate and ATP Depletion Measured by Magnetic Resonance Spectroscopy in Patients Receiving Maintenance Hemodialysis.应用磁共振波谱测量维持性血液透析患者细胞内磷酸盐和三磷酸腺苷耗竭。
J Am Soc Nephrol. 2021 Jan;32(1):229-237. doi: 10.1681/ASN.2020050716. Epub 2020 Oct 22.
5
A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD).一项关于降低 CKD 患者磷酸盐水平对血管终点影响的随机试验(IMPROVE-CKD)。
J Am Soc Nephrol. 2020 Nov;31(11):2653-2666. doi: 10.1681/ASN.2020040411. Epub 2020 Sep 11.
6
High phosphate actively induces cytotoxicity by rewiring pro-survival and pro-apoptotic signaling networks in HEK293 and HeLa cells.高磷酸盐通过重排 HEK293 和 HeLa 细胞中促生存和促凋亡信号网络,积极诱导细胞毒性。
FASEB J. 2021 Jan;35(1):e20997. doi: 10.1096/fj.202000799RR. Epub 2020 Sep 6.
7
Selective pharmacological inhibition of the sodium-dependent phosphate cotransporter NPT2a promotes phosphate excretion.选择性抑制钠依赖性磷酸盐协同转运蛋白 NPT2a 可促进磷酸盐排泄。
J Clin Invest. 2020 Dec 1;130(12):6510-6522. doi: 10.1172/JCI135665.
8
Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms.亚铁转运蛋白结合血红素肽的结构揭示了铁稳态的机制。
Nature. 2020 Oct;586(7831):807-811. doi: 10.1038/s41586-020-2668-z. Epub 2020 Aug 19.
9
Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD).促红细胞生成素和低氧诱导因子脯氨酰羟化酶抑制剂(HIF-PHDi)可降低慢性肾脏病(CKD)模型中的 FGF23。
Physiol Rep. 2020 Jun;8(11):e14434. doi: 10.14814/phy2.14434.
10
Associations of Hemoglobin Levels With Health-Related Quality of Life, Physical Activity, and Clinical Outcomes in Persons With Stage 3-5 Nondialysis CKD.血红蛋白水平与 3-5 期非透析 CKD 患者健康相关生活质量、体力活动及临床结局的相关性。
J Ren Nutr. 2020 Sep;30(5):404-414. doi: 10.1053/j.jrn.2019.11.003. Epub 2020 Jan 21.